Proteomic analysis of human plasma samples from cancer patients

Closed Solicitation Posted

Solicitation number
75F40124R00085
Agency
Responses due
Set-aside
Total Small Business

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services Food and Drug Administration (FDA) is seeking a contractor to conduct quantitative proteomic analysis of human plasma samples from cancer patients. The requirement involves measuring over 5,000 proteins across 100 plasma samples using multiplex immunoassays, with high sensitivity, specificity, and reproducibility. The analysis should span various biological processes related to cardiovascular disease, cancer, cardiometabolism, and inflammation. The analysis will be conducted at the contractor's labs, and all data will be provided to the FDA's National Center for Toxicological Research in Excel and/or PDF formats. This is a one-time analysis with a 60-day delivery timeline after receipt of samples. Proposals are due by 12PM EST on July 14, 2023.

This solicitation is set aside for small businesses under NAICS code 541380 - Testing Laboratories and Services. The procurement is classified under the PSC category AJ13-P, which covers General Science & Technology R&D Services. The government has not provided any information about potential incumbents or the expected award value range.

Notice text

Title: Proteomic analysis of human plasma samples from cancer patients

Questions due 12PM EST July 05, 2023

Proposal due 12PM EST July 14, 2023

 

Files

File Type Posted
75F40124R00085.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors